Last Price$302.80.6%
Market Cap$17.3B
P/OCF LTM
93.6x
5Y avg
20.9x
Medical - Healthcare Plans industry
median
14.4x
Stock quality & Intrinsic value
6/10
0.4% undervalued
Molina Healthcare, Inc. P/OCF LTM
Annual
Quarterly
Daily
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/OCF LTM | 7.1x | 9.0x | 7.4x | 18.2x | 3.1x | 25.2x | 3.3x | 3.7x | 8.1x | 2.8x | 3.0x | 3.5x | 4.4x | (20.5x) | 30.6x | 19.8x | 6.6x | 12.1x | 9.8x | 93.6x |
Overvalued or undervalued?
Check the intrinsic value for MOH
and see if it's the right time to invest.
Molina Healthcare, Inc. (MOH) P/OCF LTM comparison analysis
General
LTM P/OCF LTM
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
Molina Healthcare, Inc.MOH
26.9x
19.3%
9.2%
2.9%
Median Peer Set
14.4x
8.4%
(18.9%)
1.2%
Centene CorporationCNC
189.0x
5.9%
27.4%
2.0%
Alignment Healthcare, Inc.ALHC
89.3x
27.2%
(4.8%)
(8.1%)
UnitedHealth Group IncorporatedUNH
18.0x
8.9%
(35.7%)
3.6%
Elevance Health Inc.ELV
15.6x
3.2%
(0.0%)
3.4%
Clover Health Investments, Corp.CLOV
14.4x
(41.5%)
(31.3%)
(10.5%)
Humana Inc.HUM
10.6x
10.7%
(50.1%)
1.0%
CVS Health CorporationCVS
9.0x
4.2%
(43.6%)
1.2%
Cigna CorporationCI
8.4x
8.4%
(18.9%)
2.6%
Oscar Health, Inc.OSCR
3.8x
56.5%
N/A
0.3%
MOH key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,650.1 40.4% | 2,005.0 21.5% | 2,492.5 24.3% | 3,112.4 24.9% | 3,669.4 17.9% | 4,086.0 11.4% | 4,769.9 16.7% | 6,028.8 26.4% | 6,588.9 9.3% | 9,666.6 46.7% | 14,072.0 45.6% | 17,711.0 25.9% | 19,883.0 12.3% | 18,890.0 (5.0%) | 16,829.0 (10.9%) | 19,423.0 15.4% | 27,771.0 43.0% | 31,974.0 15.1% | 34,072.0 6.6% | 40,650.0 19.3% |
| Cost of Goods Sold (COGS) | 1,424.9 | 1,678.7 | 2,080.1 | 2,621.3 | 3,176.2 | 3,449.5 | 4,004.0 | 5,397.0 | 5,713.6 | 8,616.1 | 12,434.0 | 15,941.0 | 18,003.0 | 16,266.0 | 14,394.0 | 16,746.0 | 24,491.0 | 28,048.0 | 29,738.0 | 0.0 |
% margin | 225.2 13.6% | 326.3 16.3% | 412.4 16.5% | 491.1 15.8% | 493.1 13.4% | 636.5 15.6% | 766.0 16.1% | 631.8 10.5% | 875.3 13.3% | 1,050.5 10.9% | 1,638.0 11.6% | 1,770.0 10.0% | 1,880.0 9.5% | 2,624.0 13.9% | 2,435.0 14.5% | 2,677.0 13.8% | 3,280.0 11.8% | 3,926.0 12.3% | 4,334.0 12.7% | 40,650.0 100.0% |
| Operating Expenses | 179.4 | 250.5 | 314.0 | 378.4 | 437.3 | 531.5 | 621.2 | 596.3 | 738.7 | 857.6 | 1,251.0 | 1,532.0 | 1,731.0 | 1,432.0 | 1,385.0 | 1,599.0 | 2,260.0 | 2,545.0 | 2,761.0 | 38,943.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 163.3 | 229.1 | 285.3 | 344.8 | 399.1 | 346.0 | 415.9 | 532.6 | 666.0 | 764.7 | 1,147.0 | 1,393.0 | 1,594.0 | 1,333.0 | 1,296.0 | 1,480.0 | 2,068.0 | 2,311.0 | 2,462.0 | 2,743.0 |
% margin | 45.8 2.8% | 75.8 3.8% | 98.3 3.9% | 112.6 3.6% | 57.4 1.6% | 105.0 2.6% | 80.2 1.7% | 35.5 0.6% | 136.6 2.1% | 192.9 2.0% | 387.0 2.8% | 238.0 1.3% | (555.0) (2.8%) | 1,131.0 6.0% | 1,044.0 6.2% | 1,078.0 5.6% | 1,020.0 3.7% | 1,173.0 3.7% | 1,573.0 4.6% | 1,707.0 4.2% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 87.0 | 102.0 | 120.0 | 110.0 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 4.6 | 8.7 | 13.8 | 15.5 | 15.5 | 16.8 | 52.1 | 56.8 | 67.0 | 101.0 | 118.0 | 115.0 | 87.0 | 102.0 | 120.0 | 110.0 | 109.0 | 118.0 |
| Pre-tax Income | 43.9 | 73.5 | 93.7 | 103.9 | 43.6 | 89.5 | 64.7 | 19.1 | 81.1 | 135.3 | 322.0 | 137.0 | (612.0) | 999.0 | 972.0 | 961.0 | 875.0 | 1,063.0 | 1,464.0 | 1,589.0 |
% effective tax rate | 16.3 37.1% | 27.7 37.8% | 35.4 37.7% | 41.5 39.9% | 12.7 29.2% | 34.5 38.6% | 43.8 67.8% | 9.3 48.6% | 36.3 44.8% | 72.7 53.8% | 179.0 55.6% | 129.0 94.2% | (100.0) 16.3% | 292.0 29.2% | 235.0 24.2% | 288.0 30.0% | 216.0 24.7% | 271.0 25.5% | 373.0 25.5% | 410.0 25.8% |
% margin | 27.6 1.7% | 45.7 2.3% | 58.3 2.3% | 62.4 2.0% | 30.9 0.8% | 55.0 1.3% | 20.8 0.4% | 9.8 0.2% | 52.9 0.8% | 62.2 0.6% | 143.0 1.0% | 8.0 0.0% | (512.0) (2.6%) | 707.0 3.7% | 737.0 4.4% | 673.0 3.5% | 659.0 2.4% | 792.0 2.5% | 1,091.0 3.2% | 1,179.0 2.9% |
| EPS | 0.67 | 1.09 | 1.37 | 1.50 | 0.79 | 1.34 | 0.45 | 0.21 | 1.16 | 1.33 | 2.75 | 0.93 | (9.14) | 10.61 | 11.85 | 11.41 | 11.40 | 13.70 | 18.71 | 20.43 |
| Diluted EPS | 0.65 | 1.08 | 1.37 | 1.50 | 0.79 | 1.32 | 0.45 | 0.21 | 1.13 | 1.29 | 2.58 | 0.92 | (9.14) | 10.55 | 11.48 | 11.24 | 11.25 | 13.54 | 18.78 | 20.43 |
% margin | 60.9 3.7% | 97.3 4.9% | 126.3 5.1% | 146.3 4.7% | 94.0 2.6% | 165.8 4.1% | 210.2 4.4% | 118.3 2.0% | 214.1 3.2% | 332.7 3.4% | 514.0 3.7% | 488.0 2.8% | (316.0) (1.6%) | 1,241.0 6.6% | 1,148.0 6.8% | 1,151.0 5.9% | 1,126.0 4.1% | 1,349.0 4.2% | 1,744.0 5.1% | 1,893.0 4.7% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Molina Healthcare, Inc.'s P/OCF LTM?
As of today, Microsoft Corp's last 12-month P/OCF LTM is 93.6x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual P/OCF LTM for Molina Healthcare, Inc. have been 21.4x over the past three years, and 22.0x over the past five years.
2) Is Molina Healthcare, Inc.'s P/OCF LTM Good?
As of today, Molina Healthcare, Inc.'s P/OCF LTM is 93.6x, which is higher than industry median of 14.4x. It indicates that Molina Healthcare, Inc.'s P/OCF LTM is Bad.